
The medical device sector is grappling with a wave of new and proposed tariffs that have lifted costs for metals, electronics, and finished components throughout global supply chains. Manufacturers must decide whether to absorb these higher expenses, pass them to hospitals, or delay R&D investments, straining already tight pricing and regulatory pressures. Smaller and mid‑sized firms face heightened risk of consolidation as supply‑chain uncertainty hampers capital planning. Clinicians worry that rising device prices and reduced innovation could limit patient access to essential technologies.

Virtual care has shifted from a convenience to a core delivery model, prompting physicians to rethink how they build trust through a screen. Small adjustments in communication style, workflow, and technology can deepen patient connections and mitigate the risk of...

Novo Nordisk has filed a patent lawsuit against telehealth firm Hims & Hers, alleging illegal compounding of semaglutide after the FDA declared the drug no longer in shortage. The case targets the surge in compounded Wegovy and Ozempic that emerged...

The Identity Theft Resource Center’s 2025 Data Breach Report reveals a 79 % surge in U.S. data compromises, with 534 incidents targeting health‑care providers. Private‑practice physicians face precise, AI‑driven attacks that exploit patient records and vendor relationships. Transparency in breach notifications...

Physician non‑compete agreements are back in the spotlight as the FTC signals a targeted crackdown on contracts it deems unreasonable, rather than pursuing a sweeping federal ban. The debate pits practice protection against clinician mobility and continuity of care. Medical...